Aurora Spine receives lumbar spinal stenosis indication for minimally invasive implants
Click Here to Manage Email Alerts
Aurora Spine Corporation has announced FDA clearance of a new lumbar spinal stenosis indication for use with Aurora’s ZIP platform of minimally invasive spine surgery implants, according to a press release.
Other FDA-cleared indications for use of the ZIP minimally invasive (MIS) interspinous fusion system include degenerative disc disease, spondylolisthesis, trauma and tumors.
“The receipt of the additional lumbar spinal stenosis indication for our ZIP MIS interspinous fusion system is another key milestone for Aurora Spine and allows us to expand our spinal product portfolio. This achievement is a testament to the ongoing dedication and perseverance of our team,” Trent J. Northcutt, president and CEO of Aurora Spine, said in the release. “I am delighted we have obtained the additional FDA indication, especially given the overwhelming response for the ZIP devices. The success of our screwless spine procedure is a testament to our laser focus on disruptive technology and our commitment to ‘simplifying the complex,’” Northcutt added.
Read more about
Click Here to Manage Email Alerts